MSSA and MRSA Screening in Patients Undergoing Elective TJA: the Benefits of Next-generation Sequencing
Status unconfirmed
Conditions studied: Staphylococcus Aureus, Next Generation Sequencing, Total Joint Arthroplasty
In brief
The aims of this study were to evaluate the diagnostic performance of molecular and culture techniques in S. aureus screening using paired nasal and groin swabs, to determine, if any, discrepancy between the diagnostic techniques and to model the potential effect of different diagnostic techniques on S. aureus detection in orthopaedic patients
Key facts
- Study ID
- NCT04574752
- Run by
- Rothman Institute Orthopaedics
- People needed
- 163
- Starts
- 2020-08-30
- Expected to finish
- 2021-08-30
- Last updated by the study team
- 2020-10-05
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- All patients undergoing primary total knee or total hip arthroplasty at our institution will be eligible.
You may not qualify if…
- Patients included in other prospective studies
Where it is running
- Rothman Orthopaedic Institute — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.